ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Farxiga Granted Fast Track Designation for Heart Failure Following Acute Myocardial Infarction
July 24, 2020AstraZeneca has been granted Fast Track Designation in the US for the development of Farxiga (dapagliflozin) to reduce the risk of hospitalization for heart failure (hHF) or cardiovascular (CV) death in adults following an acute myocardial infarction ...
Pharma Sources Insight January 2025
